HighTower Advisors
WVE icon

HighTower Advisors’s Wave Life Sciences WVE Stock Holding History

HighTower Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Sell
22,234
-6,998
-24% -$46.4K ﹤0.01% 3621
2026
Q1 		$212K Buy
29,232
+6,402
+28% +$83.4K ﹤0.01% 3440
2025
Q4 		$388K Buy
22,830
+10,666
+88% +$108K ﹤0.01% 2828
2025
Q3 		$89K Buy
+12,164
New +$98.4K ﹤0.01% 3557

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

HighTower Advisors's WVE Position: Q2 2026 in Review

HighTower Advisors reduced its Wave Life Sciences (WVE) stake by 24% in Q2 2026, selling an estimated $46.4K and leaving 22,234 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #3621.

HighTower Advisors first reported a position in WVE in Q3 2025 and has held it in 4 quarters since. The position peaked at $388K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • HighTower Advisors held 22,234 shares of Wave Life Sciences worth $129K as of Q2 2026.
  • HighTower Advisors sold 6,998 Wave Life Sciences shares in Q2 2026, an estimated $46.4K.
  • Wave Life Sciences made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3621 holding.
  • HighTower Advisors first reported a position in Wave Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • HighTower Advisors's Wave Life Sciences position peaked at $388K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.